Les Kaplan
Director/Board Member chez NICOX SA
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michele Garufi | M | 70 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 28 ans |
Stephen Davis | M | 63 | 10 ans | |
Diane Tang-Liu | M | - |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | 9 ans |
Lauren Silvernail | F | 65 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 16 ans |
Jean-François Labbé | M | 73 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 14 ans |
Gavin M. Spencer | M | 53 | 19 ans | |
Luzi Andreas von Bidder | M | 71 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 ans |
Stephen Biggar | M | 53 | 11 ans | |
Adrienne Graves | M | 69 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 ans |
Daniel Bradbury | M | 62 |
Keck Graduate Institute of Applied Life Sciences
| 18 ans |
Bob Mischler | M | - | 9 ans | |
Laura Brege | F | 66 | 16 ans | |
Don Soland | M | 65 | 9 ans | |
Emmanuelle Pierry | F | - | 22 ans | |
Stephen Eck | M | 69 |
Keck Graduate Institute of Applied Life Sciences
| - |
Jamie Dananberg | M | 66 |
Keck Graduate Institute of Applied Life Sciences
| - |
Paul Manning | M | 68 |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | - |
Doug Hubatsch | M | - | 3 ans | |
Sandrine Gestin | F | 56 | 25 ans | |
Sheldon M. Schuster | M | - |
Keck Graduate Institute of Applied Life Sciences
| - |
Rob Ackles | M | - | 10 ans | |
Bonnie Anderson | F | 66 |
Keck Graduate Institute of Applied Life Sciences
| - |
George Golumbeski | M | 67 |
Keck Graduate Institute of Applied Life Sciences
| 11 ans |
Karen Bernstein | M | 71 |
Keck Graduate Institute of Applied Life Sciences
| 15 ans |
Vincent R. Anicetti | M | 69 |
Keck Graduate Institute of Applied Life Sciences
| 13 ans |
Barbara Kosacz | F | 66 |
Keck Graduate Institute of Applied Life Sciences
| - |
Rodney Markin | M | 67 |
Keck Graduate Institute of Applied Life Sciences
| 9 ans |
Dennis Fenton | M | 72 |
Keck Graduate Institute of Applied Life Sciences
| - |
Clifford A. Miller | M | - |
Keck Graduate Institute of Applied Life Sciences
| - |
Larry Gold | M | 82 |
Keck Graduate Institute of Applied Life Sciences
| - |
Alice T. Kane | F | 76 |
Keck Graduate Institute of Applied Life Sciences
| - |
Catherine Burzik | F | 73 |
Keck Graduate Institute of Applied Life Sciences
| - |
Yiu Nam Lau | M | 63 |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | - |
Jinn Wu | M | 75 |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | 8 ans |
Billy Tauzin | M | 81 |
Keck Graduate Institute of Applied Life Sciences
| - |
Kiran Mazumdar-Shaw | F | 71 |
Keck Graduate Institute of Applied Life Sciences
| - |
Mark Stevenson | M | 61 |
Keck Graduate Institute of Applied Life Sciences
| - |
Jay Flatley | M | 71 |
Keck Graduate Institute of Applied Life Sciences
| - |
Bob E. Curry | M | 77 |
Keck Graduate Institute of Applied Life Sciences
| - |
Chung Chiang Hsu | M | 75 |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | - |
Michael Smith | M | 79 |
Keck Graduate Institute of Applied Life Sciences
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 94 | 94,00% |
France | 11 | 11,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Les Kaplan
- Réseau Personnel